Suppr超能文献

表达 TRAIL 的 CD8+ T 细胞介导可溶性肽诱导的外周 T 细胞耗竭后的耐受。

TRAIL-expressing CD8+ T cells mediate tolerance following soluble peptide-induced peripheral T cell deletion.

机构信息

Department of Urology, University of Iowa, Iowa City, Iowa 52242-1089, USA.

出版信息

J Leukoc Biol. 2010 Dec;88(6):1217-25. doi: 10.1189/jlb.0610343. Epub 2010 Aug 31.

Abstract

Peripheral tolerance controls the action of self-reactive T cells that escape thymic deletion. We showed previously that deletion of Ag-specific CD4+ T cells induced a CD8+ T(reg) population that maintained tolerance by deleting T cells with the same Ag specificity. The present study explored the mechanism of action of these CD8+ T(reg). Following OT-II T cell deletion by soluble OVA₃₂₃₋₃₃₉, B6 mice were unresponsive to challenge after CFA/OVA immunization, and Trail⁻/⁻ or Dr5⁻/⁻ mice were immune, although all strains displayed similar OT-II peripheral deletion. Interestingly, B6 mice remained tolerant to OVA even after a second infusion of OT-II T cells. Tolerance could be transferred to naïve recipients using CD8+ T cells from B6 or Dr5⁻/⁻ mice that experienced peptide-induced peripheral OT-II deletion but not from Trail⁻/⁻ mice. Subsequent investigation found that the mechanism of action of the CD8+ T(reg) was TRAIL-mediated OT-II T cell deletion in a TCR-specific manner. Furthermore, the tolerance was transient, as it was established by 14 days after peptide injection but lost by Day 56. Together, these data provide evidence to suggest that the mechanism behind transient peripheral tolerance induced following T cell deletion is the cytotoxic activity of TRAIL-expressing CD8+ T(reg).

摘要

外周耐受控制着逃避胸腺删除的自身反应性 T 细胞的作用。我们之前曾表明,特异性 Ag 的 CD4+T 细胞的删除诱导了 CD8+T(reg)群体,该群体通过删除具有相同 Ag 特异性的 T 细胞来维持耐受。本研究探讨了这些 CD8+T(reg)的作用机制。在可溶性 OVA₃₂₃₋₃₃₉诱导 OT-II T 细胞删除后,B6 小鼠在 CFA/OVA 免疫后对挑战无反应,而 Trail⁻/⁻或 Dr5⁻/⁻小鼠具有免疫性,尽管所有品系均显示出相似的 OT-II 外周删除。有趣的是,即使在第二次输注 OT-II T 细胞后,B6 小鼠仍对 OVA 保持耐受。使用经历肽诱导外周 OT-II 删除的 B6 或 Dr5⁻/⁻小鼠的 CD8+T 细胞,但不能使用 Trail⁻/⁻小鼠的 CD8+T 细胞,可以将耐受转移到幼稚受体。随后的研究发现,CD8+T(reg)的作用机制是以 TCR 特异性方式通过 TRAIL 介导的 OT-II T 细胞删除。此外,这种耐受是短暂的,因为它在肽注射后 14 天建立,但在第 56 天失去。综上所述,这些数据提供了证据表明,T 细胞删除后诱导的短暂外周耐受的背后机制是表达 TRAIL 的 CD8+T(reg)的细胞毒性活性。

相似文献

引用本文的文献

4
Therapeutic applications of TRAIL receptor agonists in cancer and beyond.TRAIL受体激动剂在癌症及其他领域的治疗应用。
Pharmacol Ther. 2015 Nov;155:117-31. doi: 10.1016/j.pharmthera.2015.09.001. Epub 2015 Sep 5.
5
Impact of sepsis on CD4 T cell immunity.脓毒症对CD4 T细胞免疫的影响。
J Leukoc Biol. 2014 Nov;96(5):767-77. doi: 10.1189/jlb.5MR0114-067R. Epub 2014 May 2.

本文引用的文献

2
Mechanisms maintaining peripheral tolerance.维持外周耐受的机制。
Nat Immunol. 2010 Jan;11(1):21-7. doi: 10.1038/ni.1817. Epub 2009 Dec 17.
5
Immunogenic and tolerogenic cell death.免疫原性和耐受性细胞死亡
Nat Rev Immunol. 2009 May;9(5):353-63. doi: 10.1038/nri2545.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验